INtervention Study In overweiGHT Patients With COPD

Status: Completed
Location: See all (39) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Symptoms of chronic obstructive pulmonary disease (COPD) and high body mass index (BMI) overlap. The investigators are trying to find out if a program proven to help people lose a modest amount of weight and increase their physical activity will improve COPD symptoms for those with a high BMI. The program uses a series of video sessions and self-study handouts focused on healthy eating and increasing physical activity, and encourages participants to monitor their weight, diet, and physical activity for one year. For those who want to, they will be able to work with a health coach to help meet weight and activity goals. We hope that the program will lead to improved exercise tolerance, body weight, dyspnea, generic health-related quality of life, and major cardiovascular risk factors (central obesity by waist circumference, Framingham Risk Score, and blood pressure) through 12 months of follow-up. To be in the study, participants will need to have COPD, high BMI, history of smoking, shortness of breath, and be at least 40 years old.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• 40 years or older at time of eligibility screening;

• Body mass index 25.0-44.9 kg/m2 (also see Figure 2);

• Smoked more than 10 pack-years of cigarettes;

• Shortness of breath;

• COPD;

• Able to participate fully in all study protocol/procedures including written informed consent process.

Locations
United States
Alabama
Birmingham VA Medical Center
Birmingham
University of Alabama at Birmingham - UAB Lung Health Center
Birmingham
Arizona
University of Arizona
Tucson
California
University of California, Los Angeles
Los Angeles
Universtiy of California, San Francisco
San Francisco
Colorado
National Jewish Health
Denver
Connecticut
Waterbury Pulmonary Associates
Waterbury
Florida
Sarasota Memorial Hospital
Sarasota
Iowa
University of Iowa
Iowa City
Illinois
Northwestern University - Northwestern Medical Group - Pulmonology
Chicago
University of Illinois, Chicago - Division of Pulmonay, Critical Care, Sleep & Allergy
Chicago
Massachusetts
Boston VA Medical Center
Boston
Baystate Health
Springfield
Maryland
Johns Hopkins University - Pulmonary & Critical Care Medicine
Baltimore
University of Maryland
Baltimore
Maine
Chest Medicine
South Portland
Michigan
University of Michigan - Division of Pulmonary & Critical Care Medicine
Ann Arbor
Minnesota
Minneapolis VA Health Care System - Pulmonology
Minneapolis
Minnesota Health Partners
Saint Paul
Missouri
St. Louis VA
Saint Louis
North Carolina
Duke University
Durham
East Carolina University - Pulmonary, Critical Care & Sleep Medicine
Greenville
New York
Albany Medical College
Albany
Buffalo VA Medical Center
Buffalo
University of Buffalo
Buffalo
NYU Winthrop
Mineola
Ohio
Case Western
Cleveland
Ohio State University
Columbus
Pennsylvania
Geisinger Medical Center
Danville
Penn State Milton S. Hershey Medical Center - Pulmonary, Allergy & Critical Care Medicine
Hershey
Temple University Hospital - Temple Lung Center
Philadelphia
University of Pittsburgh Medical Center - Kaufmann Building
Pittsburgh
South Carolina
Medical University of South Carolina
Charleston
Texas
BSW Research
Dallas
Baylor College of Medicine
Houston
Grand Medical Clinic
Katy
Utah
University of Utah
Salt Lake City
Vermont
White River Junction VA
White River Junction
Washington
VA Puget Sound Health Care System
Seattle
Time Frame
Start Date: 2017-05-12
Completion Date: 2020-10-30
Participants
Target number of participants: 684
Treatments
Active_comparator: Lifestyle intervention
Behavioral lifestyle intervention focused on healthy eating and physical activity
No_intervention: Usual Care
Participants continue with usual diet and exercise activities as they desire
Sponsors
Collaborators: VA Puget Sound Health Care System, University of Illinois at Chicago
Leads: Seattle Institute for Biomedical and Clinical Research

This content was sourced from clinicaltrials.gov